Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Update on the DARE-19 Phase III trial for Farxiga in COVID-19
-
AstraZeneca accelerates early oncology pipeline across key strategic scientific platforms at AACR
-
AZD1222 US Phase III primary analysis confirms safety and efficacy
-
Statement on COVID-19 vaccine supply at Anagni plant in Italy
-
Update following statement by NIAID on AZD1222 US Phase III trial data
-
AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis
-
Statement on the passing of José Baselga
-
UK and EU regulatory agencies confirm COVID-19 Vaccine AstraZeneca is effective and generally well-tolerated
-
Divestment of Viela shareholding completed
-
AstraZeneca to supply the US with up to half a million additional doses of the potential COVID-19 antibody treatment AZD7442
Latest articles and press releases
All of our latest press releases and articles are available to explore
